Influential Businesswoman Awards 2024, Acquisition International | 47 Therapeutics Consumer Strategy Businesswoman of the Year 2024 (USA): Hebe Berger esponsible for crafting a tangible, multichannel engagement strategy for Incyte’s impact on the region of North America, Hebe Berger is a talented woman whose broad skillset has played a pivotal role in the company’s excellent reputation. Since onboarding her position within Incyte in 2021, Hebe has demonstrated an affinity for not only devising omnichannel plans that heavily focus on digital channels, but also orchestrating the dissemination of educational content – be it to patients, healthcare professionals, or even payers. She achieves such a feat while simultaneously working with various teams across the sector, all in the hopes of creating a steadfast network built on mutual respect and support. Though intricate, Hebe is able to continuously champion her role for the sake of elevating Incyte beyond its regional standing. As a direct result, she has already fostered worldwide recognition for the brand, encouraging different areas of the organisation to communicate and engage with clients in ways they may have never considered. In essence, collaboration is the cornerstone of Hebe’s approach, allowing her to connect with a myriad of individuals in inspired and fascinating ways. Whether she’s sharing her knowledge of digital channel strategy, direct to consumer processes, or healthcare professional marketing, Hebe excels at impressing those around her. However, before she began her journey at Incyte, Hebe found herself spending six years dedicated to overseeing UnitedHealth Group’s payer-to-HCP marketing strategy department. For the most part, this role would involve Hebe gaining a thorough understanding of policy communication regarding benefits, coverage determination, clinical diagnosis, and procedures across a myriad of therapeutic areas. Partnered with her pivotal multichannel marketing responsibilities, Hebe was able to onboard a vast array of invaluable skills that, when applied to Incyte, would ultimately trigger succession on an entirely new scale. Though, in today’s age, there are more women in pharmaceuticals than ever before, these strides haven’t been particularly easy to take. Mostly encouraged by male allies and mentors, women in the healthcare industry have been moving forward at a more gradual space, even more so when it comes to leadership and executive roles. Even now, women in these positions are few and far between, deemed to be an unfortunate minority. Hebe, however, was determined to overcome these statistics and set her mind to becoming an integral part of the industry’s growth. Surely enough, through hard work, dedication, and an uncontested level of passion, Hebe Berger has managed to drive change and challenge the status quo. As a Latina woman, she has always felt the need to prove herself to her coworkers, peers, and leaders throughout the years, and she now stands as a testament to the notion that one’s skills – regardless of gender – can speak for themselves. She stood her ground in order to seize opportunities, and she believes that it’s this very approach that finally earned her such an incredible level of respect from those around her. The Influential Businesswoman Awards 2024 present exceptional businesswomen with the chance to showcase their accomplishments within their respective industries. Hebe Berger is one such woman – someone who never let her dreams dwindle, and instead rose up to achieve the goals she laid out at the beginning of her career. We’re delighted to have the chance to shed some light on such an influential woman, and we hope her excellence continues to flourish throughout Incyte’s future endeavours. Contact: Hebe Berger Company: Incyte Web Address: https://incyte.com/ Centred around cultivating solutions for typically unmet medical needs, Incyte is a biopharmaceutical company that leverages its knack for discovery and development to present proprietary therapeutics to a global audience. Beginning its venture in 2002, the collective has since grown into a worldwide organisation whose portfolio of treatments has played a critical role in the treatment of various oncological, inflammation, and autoimmune conditions. Spearheading its success is award-winning Hebe Berger – a woman whose influence has reshaped Incyte’s industry pathing for the foreseeable future. R
RkJQdWJsaXNoZXIy MjQyNzgzNA==